Bortezomib, doxorubicin and dexamethasone association is an effective option for plasma cell leukemia induction therapy.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Didier Bouscary Jerome Tamburini Nicolas Chapuis Valérie Bardet |
| Publication date | October 1, 2008 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |